Missing/wrong data?
Log in to edit
Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
scientific article published on March 10, 2016
Author/s
author: Barbara Pro, Steven M Horwitz, H. Miles Prince
Work details
Publication date
March 10, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.